Completed PHASE3 INTERVENTIONAL 1-arm NCT00536666

A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients

A Non-Comparative Open-Label Study of Iron Oligosaccharide in Chronic Kidney Disease Patients With a Need for Parenteral Iron

Sponsor: Pharmacosmos A/S

Conditions Anemia, Iron-Deficiency Chronic Kidney Disease

Interventions Iron oligosaccharide

Updated 5 times since 2017 Last updated: Oct 7, 2008 Started: May 31, 2007 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00536666, this PHASE3 trial focuses on Anemia, Iron-Deficiency and Chronic Kidney Disease and remains completed. Sponsored by Pharmacosmos A/S, it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Pharmacosmos A/S

Data source: Pharmacosmos A/S

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark